Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Talarozole (R115866) is an oral systemic all-trans retinoic acid metabolism blocking agent (RAMBA). Talarozole inhibits both CYP26A1 and CYP26B1 with IC50s of 5.4 and 0.46 nM, respectively.Talarozole for the treatment of acne, psoriasis and other keratinization disorders.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 66.00 | |
2 mg | In stock | $ 97.00 | |
5 mg | In stock | $ 137.00 | |
10 mg | In stock | $ 177.00 | |
25 mg | In stock | $ 286.00 | |
50 mg | In stock | $ 393.00 | |
100 mg | In stock | $ 585.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 113.00 |
Description | Talarozole (R115866) is an oral systemic all-trans retinoic acid metabolism blocking agent (RAMBA). Talarozole inhibits both CYP26A1 and CYP26B1 with IC50s of 5.4 and 0.46 nM, respectively.Talarozole for the treatment of acne, psoriasis and other keratinization disorders. |
Targets&IC50 | CYP26B1/A1:0.46/5.1 nM (IC50) |
Synonyms | R115866 |
Molecular Weight | 377.51 |
Formula | C21H23N5S |
CAS No. | 201410-53-9 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 36 mg/mL (95.36 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Talarozole 201410-53-9 Autophagy Metabolism Others Retinoid Receptor P450 Retinoid X receptors R-115866 Retinoic acid receptors R115866 RAR/RXR inhibit Cytochrome P450 CYPs Inhibitor R 115866 inhibitor